Company / Operating Cash Flow
Harvard Apparatus Regenerative Technology, Inc. Operating Cash Flow History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$3.8M
FY2025
5-year range
-$6.9M / -$2.6M
FY2021-FY2025
Trend
+21.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$11M in FY2017 to -$3M in FY2021.
Based on SEC 10-K filings.
-$4M in FY2025.
Improved from -$7M to -$4M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 21.1% year-over-year.
- Peak operating cash flow was recorded in FY2021.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.8M | +21.1% |
| FY2024 | -$4.9M | +30.1% |
| FY2023 | -$6.9M | -164.0% |
| FY2021 | -$2.6M | +35.0% |
| FY2020 | -$4.0M | +33.3% |
| FY2019 | -$6.1M | +20.7% |
| FY2018 | -$7.6M | +30.7% |
| FY2017 | -$11.0M | -21.6% |
| FY2016 | -$9.1M | -26.1% |
| FY2015 | -$7.2M | +10.1% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026